Poly-benzimidazole with pyrene and anthracene flourophore
US-2016369057-A1 · Dec 22, 2016 · US
US9267930B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9267930-B2 |
| Application number | US-201213653474-A |
| Country | US |
| Kind code | B2 |
| Filing date | Oct 17, 2012 |
| Priority date | Oct 17, 2012 |
| Publication date | Feb 23, 2016 |
| Grant date | Feb 23, 2016 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
Described herein are new recognition elements (antibodies or functional fragments thereof) that effectively bind to trinitrotoluene (TNT). Also disclosed is a single chain fragment recognition element.
Opening claim text (preview).
What is claimed is: 1. An isolated antibody or functional fragment thereof that binds to trinitrotoluene, comprising a heavy chain having a sequence of SEQ ID NO:1 and a light chain having a sequence of SEQ ID NO:2. 2. The isolated antibody or functional fragment thereof according to claim 1 , wherein the antibody or functional fragment thereof is a single chain variable fragment. 3. The isolated antibody or functional fragment thereof according to claim 1 , wherein the isolated antibody or functional fragment thereof is a single chain antibody, wherein the combined heavy and light chain have a sequence of SEQ ID NO:3. 4. An isolated nucleic acid molecule comprising a nucleotide encoding the isolated antibody or functional fragment thereof according to claim 1 . 5. A host cell in vitro transformed with the isolated nucleic acid molecule according to claim 4 . 6. A method of producing an antibody or functional fragment thereof, the method comprising culturing host cells according to claim 5 under conditions for production of the antibody or functional fragment thereof. 7. The method according to claim 6 , further comprising isolating and/or purifying the antibody or functional fragment thereof. 8. A method of detecting trinitrotoluene (TNT), the method comprising reacting a sample known or suspected of containing TNT with the isolated antibody or functional fragment thereof according to claim 1 . 9. An apparatus configured to detect trinitrotoluene (TNT), the apparatus comprising the isolated antibody or functional fragment thereof according to claim 1 .
variable (Fv) region, i.e. VH and/or VL · CPC title
Stability, e.g. half-life, pH, temperature or enzyme-resistance · CPC title
Affinity (KD), association rate (Ka), dissociation rate (Kd) or EC50 value · CPC title
for analytes not provided for elsewhere, e.g. nucleic acids, uric acid, worms, mites · CPC title
Single domain, e.g. dAb, sdAb, VHH, VNAR or nanobody® · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.